Microplate Systems Market: Current Analysis and Forecast (2021-2027)

A microplate system is widely employed in laboratories for the measurement of chemical, biological or physical reactions, properties, and analytes within the well of a microplate. The demand for Microplate Systems is mainly increasing on account of the increasing incidence of chronic and lifestyle disorders, increasing R&D expenditure in the pharmaceutical industry, and increasing focus on miniaturization. Moreover, the rising incidence of infectious diseases led to the high demand for lab testing, and better reimbursement policies are further intensifying the market demand. For instance, as per the Centers for Disease Control and Prevention, the number of new tuberculosis cases was 9,025 and the number of new salmonella cases was 60,999 in the US region in 2018.
However, some of the restraints in the market include high operational costs and the survival of small players and new entrants.
Based on Product, the market is fragmented into Microplate Reader, Microplate Washer, and Microplate Accessories. Microplate Reader segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to the rising prevalence of diseases, the growing focus on drug discovery, and the increasing R&D expenditure by pharmaceutical companies. For instance, in 2019, research and development spending in the pharmaceutical industry was USD 186 billion globally. In comparison, the R&D expenditures totaled USD 159 billion in 2016. Further, this spending is anticipated to reach USD 233 billion by 2026.
Based on Application, the market is fragmented into Genomics and Proteomics Research, Drug Discovery, Clinical Diagnostics, and Other Applications. The drug discovery segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period due to the need for high-throughput screening techniques in computer-aided drug designs and to reduce the timeline of the development of the new drug. For instance, Synthetic Genetic Array (SGA) analysis is a type of high-throughput screening technique which involves the manipulation of high-density yeast arrays for the identification of synthetic genetic interactions.
Based on End-user, the market is fragmented into Hospital and Diagnostic Laboratories, Biotechnology, and Pharmaceutical Companies, Research and Academic Institutes. The biotechnology and pharmaceutical segment holds the largest share in 2020 and is expected to register the highest CAGR in the upcoming period owing to the increasing government support in the form of funding for biotech and pharma research. As per IBISWorld, it’s evident that biotech is a multi-billion-dollar industry. Even before 2020 came to a close, the industry market size was over $100 billion.
For a better understanding of the market adoption of Microplate Systems, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Microplate Systems market on account of the rising government initiatives for cell-based research, the high adoption of personalized medicine, rising academic and government investments in diagnostic research, and the high number of biotech companies in the US region coupled with their increasing focus on the research and development of new drugs. As per the USA Life Sciences, around 6,600 biotech companies are operating in the US region. A more in-depth analysis highlights therapeutics as the most common in the biotech landscape, making up 29.1% of all these companies. At 17.6%, analytics and diagnostics are the second most prominent field in biotech organizations. Some of the major players operating in the market include Bio-Rad Laboratories Inc., PerkinElmer, Danaher Corporation, Thermo Fisher Scientific, Agilent Technologies Inc., Tecan, BMG Labtech, Promega Corporation, Enzo Life Sciences Inc., Berthold Technologies. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.